T77062
Levilimab
TargetMol
DESCRIPTION
Levilimab (BCD-089), a fully human monoclonal antibody targeting the interleukin-6 receptor (IL-6R), serves as an inflammation-reducing agent. This compound is utilized in the study of rheumatoid arthritis [1].
DETAILS
- Cas: 2035008-70-7
- Purity: 98%
- Category: Compound
Lead Time: Please Inquire
Sign in to view pricingEquivalent Items
| ... Loading